CorMedix (CRMD) Amortization of Deferred Charges (2012 - 2025)
CorMedix (CRMD) reported Amortization of Deferred Charges of $255616.0 for Q4 2025, up 562.49% on a YoY basis from $38584.0 in Q4 2024, and up 147.36% sequentially from $103339.0 in Q3 2025.
CorMedix (CRMD) Amortization of Deferred Charges (2012 - 2025) Analysis & Trends
CorMedix (CRMD) has 8 years of Amortization of Deferred Charges data on file, last reported at $255616.0 in Q4 2025.
- For the quarter ending Q4 2025, Amortization of Deferred Charges rose 562.49% year-over-year to $255616.0; the trailing twelve-month figure through Dec 2025 stood at $438000.0 (up 195.95% YoY), and the FY2025 full-year result was $438000.0, up 195.95% from the prior year.
- Amortization of Deferred Charges climbed to $255616.0 in Q4 2025, from $103339.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $255616.0 in Q4 2025 to a low of $27878.0 in Q1 2021.
- A 5-year average of $48017.8 and a median of $33694.0 in 2023 frame the typical range for Amortization of Deferred Charges.
- Across the five-year window, Amortization of Deferred Charges gained 7.21% in 2022 and jumped 562.49% in 2025, its largest moves.
- Tracing CRMD's Amortization of Deferred Charges over 5 years: stood at $29701.0 in 2021, then increased by 7.27% to $31861.0 in 2022, then climbed by 9.34% to $34837.0 in 2023, then increased by 10.76% to $38584.0 in 2024, then jumped by 562.49% to $255616.0 in 2025.
- Business Quant data shows CRMD's Amortization of Deferred Charges at $255616.0 in Q4 2025, $103339.0 in Q3 2025, and $39981.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | CorMedix | 4.95 Mn | -150.26 Mn | 107.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 255,616.00 |
| Dec 31, 2025 | 255,616.00 |
| Sep 30, 2025 | 103,339.00 |
| Sep 30, 2025 | 103,339.00 |
| Jun 30, 2025 | 39,981.00 |
| Jun 30, 2025 | 39,981.00 |
| Mar 31, 2025 | 39,064.00 |
| Mar 31, 2025 | 39,064.00 |
| Dec 31, 2024 | 38,584.00 |
| Dec 31, 2024 | 38,584.00 |
| Sep 30, 2024 | 37,306.00 |
| Sep 30, 2024 | 37,306.00 |
| Jun 30, 2024 | 36,466.00 |
| Jun 30, 2024 | 36,466.00 |
| Mar 31, 2024 | 35,644.00 |
| Mar 31, 2024 | 35,644.00 |
| Dec 31, 2023 | 34,837.00 |
| Dec 31, 2023 | 34,837.00 |
| Sep 30, 2023 | 34,069.00 |
| Sep 30, 2023 | 34,069.00 |